Cancer

Title Average Ratingsort ascending
PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. 70.00%
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory....... 70.00%
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer. 70.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
BET bromodomain inhibition as a therapeutic strategy to target c-Myc 70.00%
Phase I study of sunitinib malate continuously dosed and standard-infusion gemcitabine in solid tumors. 70.00%
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. 70.00%
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. 70.00%
Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review 70.00%
Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines 70.00%
Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. 70.00%
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). 70.00%
The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas.' 70.00%
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. 70.00%
Medical Cannabis Compounds 70.00%
An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma. 70.00%
A phase II trial of an adenovirus/PSA vaccine for prostate cancer. 70.00%
Hyperthermia and Immunity. A Brief Overview 70.00%
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. 70.00%
Digitoxin and its analogs as novel cancer therapeutics. 70.00%
New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival? 70.00%
Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a stu 70.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients 70.00%
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial 70.00%
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. 70.00%
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic bre 70.00%
Effect of metronomic use of zoledronic acid (ZOL) on antitumor and antiosteoclastic effects in breast cancer patients with bone 70.00%
Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities. 70.00%
Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data. 70.00%
Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes 70.00%
Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. 70.00%
Focal laser ablation of prostate cancer: definition, needs, and future 70.00%
Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. 70.00%
Trans Arterial Chemo Embolization(TACE) 70.00%
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163. 70.00%
Anti-Cancer Infusions 70.00%
Clinical results of N-acetylcysteine after major hepatic surgery: a review. 70.00%
Epidemiologic evidence on coffee and cancer. 70.00%
Anti-cancer drugs that target metabolism, is dichloroacetate the new paradigm? 70.00%
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer 70.00%
Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model. 70.00%
Oncolytic virus therapy for prostate cancer. 70.00%
Association between serum 25(OH)D and death from prostate cancer. 70.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
Increased risk of cancer subsequent to severe depression--a nationwide population-based study. 70.00%
The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways 70.00%
Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. 70.00%
Oral metronomic cyclophosphamide in elderly with metastatic melanoma. 70.00%
Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. 70.00%
Radiosurgery for spinal malignant tumors. 70.00%
Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis. 70.00%
Dendritic Cell Therapy 70.00%
Antitumor activity of patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells: In vitro results and cli 70.00%
Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for NSCLC. 70.00%
Hypoxia in cancer: significance and impact on clinical outcome. 70.00%
Local ultrasound hyperthermia as a component of radiotherapy for osteogenic sarcoma of tubular bones in children and adolescents 70.00%
Homeopathy as a supportive therapy in cancer. 70.00%
Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer. 70.00%
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose-Escalation, Safety Study of the Chemot 70.00%
Garlic, or Allium sativum: a review of its potential use as an anti-cancer agent. 70.00%
Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain 70.00%
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. 70.00%
Animal studies on Ukrain 65.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can 63.33%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Ukrain 62.22%
Pycnogenol may alleviate adverse effects in oncologic treatment. 60.00%
Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and 60.00%
Systematic review of the treatment of cancer-associated anorexia and weight loss. 60.00%
Tumor pO(2) as a Surrogate Marker to Identify Therapeutic Window during Metronomic Chemotherapy of 9L Gliomas. 60.00%
Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angio.. 60.00%
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. 60.00%
Unconventional anticancer agents: a systematic review of clinical trials. 60.00%
Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare 60.00%
Beta-solamarine: tumor inhibitor isolated from Solanum dulcamara. 60.00%
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of 60.00%
Focal therapy for prostate cancer: revolution or evolution? 60.00%
Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate 60.00%
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer. 60.00%
Boswellia 60.00%
CECs, CEPs and CTCs for prediction of response in patients with advanced breast cancer (ABC) receiving metronomic vinorelbine. 60.00%
Therapeutic vaccination against advanced pancreatic cancer by autologous dendritic cells pulsed with a MUC1 peptide: Preclinic.. 60.00%
Correlation of immune responses and survival in a phase II study of belagenpumatucel-L in non-small cell lung cancer. 60.00%
Final results of a pharmacokinetic (PK) and pharmacodynamic (PD) phase I trial of ARQ 197 incorporating dynamic contrast........ 60.00%
Strong synergy of heat and modulated electromagnetic field in tumor cell killing. 60.00%
Complete remission of psoriasis following bevacizumab therapy for colon cancer. 60.00%
SWOG 0012, a randomized phase III comparison of standard doxorubicin (A) and cyclophosphamide (C) followed by weekly paclitaxel 60.00%
Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during sh 60.00%
Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma. 60.00%
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and m 60.00%
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status 60.00%
A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients wi 60.00%
A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glio.... 60.00%
Survivin and pancreatic cancer. 60.00%
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. 60.00%
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer 60.00%
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells 60.00%

Pages